Document Detail

The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers.
MedLine Citation:
PMID:  20730054     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Due to the inherent sensitivity of human embryonic stem cells (hESCs) to manipulations, the recovery and survival of hESCs after fluorescence-activated cell sorting (FACS) can be low. Additionally, a well characterized and robust methodology for performing FACS on hESCs using multiple-cell surface markers has not been described. The p160-Rho-associated coiled kinase (ROCK) inhibitor, Y-27632, previously has been identified as enhancing survival of hESCs upon single-cell dissociation, as well as enhancing recovery from cryopreservation. Here we examined the application of Y-27632 to hESCs after FACS to improve survival in both feeder-dependent and feeder-independent growth conditions.
METHODOLOGY/PRINCIPAL FINDINGS: HESCs were sorted using markers for SSEA-3, TRA-1-81, and SSEA-1. Cells were plated after sorting for 24 hours in either the presence or the absence of Y-27632. In both feeder-dependent and feeder-independent conditions, cell survival was greater when Y-27632 was applied to the hESCs after sort. Specifically, treatment of cells with Y-27632 improved post-sort recovery up to four fold. To determine the long-term effects of sorting with and without the application of Y-27632, hESCs were further analyzed. Specifically, hESCs sorted with and without the addition of Y-27632 retained normal morphology, expressed hESC-specific markers as measured by immunocytochemistry and flow cytometry, and maintained a stable karyotype. In addition, the hESCs could differentiate into three germ layers in vitro and in vivo in both feeder-dependent and feeder-independent growth conditions.
CONCLUSIONS/SIGNIFICANCE: The application of Y-27632 to hESCs after cell sorting improves cell recovery with no observed effect on pluripotency, and enables the consistent recovery of hESCs by FACS using multiple surface markers. This improved methodology for cell sorting of hESCs will aid many applications such as removal of hESCs from secondary cell types, identification and isolation of stem cell subpopulations, and generation of single cell clones. Finally, these results demonstrate an additional application of ROCK inhibition to hESC research.
Nil Emre; Jason G Vidal; Jeanne Elia; Eric D O'Connor; Rosanto I Paramban; Michael P Hefferan; Roman Navarro; Danielle S Goldberg; Nissi M Varki; Martin Marsala; Christian T Carson
Related Documents :
9720994 - Beta-chemokine expression and distribution in paraffin-embedded transplant renal biopsy...
11000434 - Gel microdroplet technique leaving microorganisms alive for sorting by flow cytometry.
2766884 - Differences in the flow and absorption cytometric dna distributions of mouse hepatocyte...
2325664 - Estradiol decreases retention of rhodamine 123 fluorescence in gh4c1 pituitary tumor ce...
20954734 - Exploring cellular contact guidance using gradient nanogratings.
9721694 - Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-13
Journal Detail:
Title:  PloS one     Volume:  5     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-23     Completed Date:  2010-11-04     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e12148     Citation Subset:  IM    
BD Biosciences, La Jolla, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amides / pharmacology*
Biological Markers / metabolism
Cell Culture Techniques
Cell Differentiation / drug effects
Embryonic Stem Cells / cytology*,  drug effects*,  metabolism
Flow Cytometry / methods*
Protein Kinase Inhibitors / pharmacology*
Pyridines / pharmacology*
rho-Associated Kinases / antagonists & inhibitors*
Reg. No./Substance:
0/Amides; 0/Biological Markers; 0/Protein Kinase Inhibitors; 0/Pyridines; 138381-45-0/Y 27632; EC Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipide...
Next Document:  Palmitic acid analogs exhibit nanomolar binding affinity for the HIV-1 CD4 receptor and nanomolar in...